Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025. The post Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why appeared first on Investor's Business Daily.

Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025.
The post Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why appeared first on Investor's Business Daily.